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Session: 51. Soft Tissue and Skin Infections
Background. Although skin and soft-tissue infections (SSTIs) remain a common cause of hospitalization for intravenous drug users (IVDU), little has been done to identify whether there should be differences in the SSTI management of IVDU vs. nonusers. The objective of this study was to evaluate the impact of documented intravenous drug abuse on the overall management of invasive SSTIs in hospitalized patients.
Methods. This retrospective cohort study randomly selected 100 IVDU and 100 nonusers (controls) hospitalized for an SSTI over 18 months in a community teaching hospital. Patients eligible for inclusion were 18-60 years old and treated with IV inpatient antibiotics for at least 48 hours. Pregnant women, transfers from an outside hospital, and diabetic foot infections were excluded. The primary endpoint was hospital length of stay (LOS). Secondary endpoints included: percentage prescribed empiric combination antibiotic therapy, percentage prescribed an anti-pseudomonal agent, inpatient and total antibiotic duration of therapy (DOT), 30-day readmission rates, and 30-day emergency department (ED) visit rates.
Results. The study population was predominantly male (66%), Caucasian (72%), and had a mean age of 40 years old (18-59). IVDU were more likely to have complications (18% vs. 6%) and polymicrobial infections (19% vs. 2%), Mean hospital length of stay was 9.0 days for IVDU compared with 4.8 days for controls (P < 0.001). There was no difference in empiric combination therapy (48% vs. 37%; P = 0.115) or empiric exposure to an anti-pseudomonal agent (38% vs. 30%; P = 0.232). Mean duration of inpatient antibiotic DOT was longer in IVDU (7.5 days vs. 4.3 days; P < 0.001), but total antibiotic DOT was similar between groups (16.0 days vs. 13.8 days; P = 0.141). Thirty-day ED visits were higher for IVDU (16% vs. 5%; P = 0.009); however, there was no difference in 30-day readmission (14% vs. 16%; P = 0.692).
Conclusion.
Documented IV drug abuse resulted in a significant increase in the length of stay in hospitalized adults with SSTIs requiring IV antibiotics. Exposure to combination therapy and anti-pseudomonal agents did not differ between the groups as would be expected. In the future stewardship initiatives are needed to increase adherence to SSTI guideline recommendations for empiric therapy.
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High Rate of Extended-Spectrum β-Lactamase Producing Gram-Negative Infections and Associated Mortality in Ethiopia: A Systematic Review and

Background.
Extended-spectrum β-lactamase (ESBL)-producing Gramnegative bacteria have become a serious threat to global health. The rapid increase of ESBL-producing bacteria is associated with high mortality due to ineffective antibiotic treatment. To date, regular surveillance of multidrug-resistant (MDR) pathogens is lacking in Ethiopia. For this report, published data regarding ESBL-producing bacteria in different regions of Ethiopia were reviewed systematically. To our knowledge, this is the first systematic review from Ethiopia on ESBL-producing infections and associated mortality in the country.
Methods. A literature search was conducted in PubMed, PubMed Central, and Google Scholar from January 1, 1990 to April 28, 2019, using the following search terms: "ESBL producing Enterobacteriaceae, " "Gram-negative bacteria infection associated mortality, " and "Ethiopia. " Patient mortality associated with infections by ESBLproducing Gram-negative bacteria was recorded.
Results. Fourteen publications qualified for review. Totally, 1,782 Gram-negative bacteria isolated from 5,191 clinical samples were included. The phenotypic pooled rate of ESBL-producing Gram-negatives was estimated to be 52.9(95% CI: 50.5%-55.4%). Among different species, ESBL rates were 65. 7% (262/399) Klebsiella spp., 60.6% (20/33) for Enterobacter spp., 47.8% (22/46) for Citrobacter spp., 47.0% (383/815) for E. coli, 45.7% (85/186) for Salmonella spp., 27.8%(15/54) for Proteus spp., 16.7%(4/24) for P. aeruginosa, 14.3% (3/21) for Acinetobacter spps., and 40.5% (15/37) for others, respectively. ESBL genes were confirmed in three studies. bla CTX-M-1 and bla TEM were the predominately detected genes. Two studies reported mortality associated with Gramnegative infections and 86% (12/14) of the patients infected with ESBL-producing bacteria died.
Conclusion. In this meta-analysis, the pooled phenotypic prevalence of ESBLproducing pathogens is considerably high. Also, the mortality due to ESBL-producers is high but data are scarce. This highlights the need for establishing and upgrading of clinical microbiology laboratories in the country for routine antibiotic susceptibility testing. The capacity to detect ESBL genes is desirable for continuous surveillance of MDR.
Disclosures. All authors: No reported disclosures. Background. Antibiotic resistance is a significant threat to public health not only in healthcare setting but also in community because antimicrobial-resistant infections can be transmitted in community. Although it is essential to know whether there are particular reasons that caused antibiotic-resistant infection in community, there is lack of evidence regarding risk factors for community-onset extended-spectrum β-lactamase-producing Klebsiella pneumoniae bloodstream infection (ESBL-KP BSI) in South Korea. In the present study, we aimed to reveal risk factors for community-onset ESBL-KP BSI.
Risk Factors of Community-Onset Extended-Spectrum β-Lactamase
Methods. From May 2016 to April 2017, patients with community-onset KP BSI (n = 408) from six sentinel hospitals in South Korea were included. The hospitals are located in different districts throughout South Korea, and had a total of 5,194 beds, ranged from 715 to 1,050 beds per hospital. Admission history and previous usage of antibiotics and medical devices before bacteremia were acquired from National Health Insurance claims data. Risk factors of ESBL-KP BSI were analyzed with a multivariable logistic regression model. PCR and sequencing for the identification of genes encoding ESBLs, and multilocus sequence typing were performed.
